Every day, literally, World-Herald staff work to bring you the news that tells you more, surprises you and connects you with others.

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives. According ...

Here’s some changes Californians can expect in the classroom in 2025 as the state wraps up a busy year in education.